M. Higgins

Identification and Preclinical Evaluation of the Bicyclic Pyrimidine γ-Secretase Modulator BMS-932481

J. Macor, A. Mathur, M. Ahlijanian, 2019, ACS medicinal chemistry letters.

Triazolopyridine ethers as potent, orally active mGlu2 positive allosteric modulators for treating schizophrenia.

M. Seager, J. Macor, A. Hendricson, 2017, Bioorganic & medicinal chemistry.

Discovery of S3-Truncated, C-6 Heteroaryl Substituted Aminothiazine β-Site APP Cleaving Enzyme-1 (BACE1) Inhibitors.

J. Macor, H. Lewis, Chiehying Y Chang, 2016, Journal of medicinal chemistry.

2-(N-Benzyl-N-phenylsulfonamido)alkyl amide derivatives as γ-secretase inhibitors.

J. Macor, D. Barten, C. Polson, 2012, Bioorganic & medicinal chemistry letters.

Dihydropyridine neuropeptide Y Y1 receptor antagonists 2. bioisosteric urea replacements.

Scott W. Martin, I. Antal-Zimanyi, J. Romine, 2004, Bioorganic & medicinal chemistry.

Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.

B. Beno, M. Cunningham, T. Molski, 2005, Journal of medicinal chemistry.

Synthesis and evaluation of 5,5-diphenylimidazolones as potent human neuropeptide Y5 receptor antagonists.

Astrid A. Ortiz, I. Antal-Zimanyi, S. Rassnick, 2006, Bioorganic & medicinal chemistry.

Identification and Preclinical Pharmacology of the γ-Secretase Modulator BMS-869780

J. Macor, M. Ahlijanian, Joseph L. Cantone, 2014, International journal of Alzheimer's disease.

Synthesis and SAR of indole-and 7-azaindole-1,3-dicarboxamide hydroxyethylamine inhibitors of BACE-1.

J. Macor, J. Marcinkeviciene, P. Morin, 2011, Bioorganic & medicinal chemistry letters.